Menu
Not yet recruiting NCT07030036

Screening for Cognitive Disorders in Multiple Sclerosis

Observational Multiple Sclerosis Cognitive Dysfunction Neuropsychological Tests Quality of Life

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Multiple Sclerosis, Cognitive Dysfunction, Neuropsychological Tests, Quality of Life. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study aims to identify cognitive problems in adults with multiple sclerosis (MS). MS can affect memory, thinking speed, and spatial skills, which may impact daily life and work. We will use simple and proven tests to check for these difficulties and see how they affect quality of life. The study will include about 60 patients followed at the neurology day hospital.

Primary outcome measures

  • Prevalence of cognitive impairment in patients with multiple sclerosis, assessed by validated cognitive tests (CSCT, RL/RI-16, Figure de REY, HAD scale, SF-12). [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • Patients aged 18 years or older
  • Diagnosed with multiple sclerosis (MS) for at least 6 months according to the 2017 McDonald criteria (SFSEP)
  • Receiving disease-modifying treatment and followed in the neurology day hospital of CH Gonesse

Exclusion criteria

\- Under 18 years old

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Study design

Observational model
Cohort

Study locations

France · 1 center
  • France — Gonesse

Identifiers

NCT: NCT07030036 · 0058_NEUROLOGIE

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗